Clinical Trial Update: Safety and Biologic Activity Study of Gevokizumab to Treat Erosive Osteoarthritis of the Hand [Phase 2]

View source ↗

Summary

Phase 2 study evaluating safety and biologic activity of gevokizumab in erosive osteoarthritis of the hand has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Erosive Osteoarthritis of the Hand
• Osteoarthritis

Drugs mentioned

• Gevokizumab (gevokizumab)

Snippet

Sponsor: XOMA (US) LLC | Conditions: Osteoarthritis | Phase 2 | Status: COMPLETED